Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Resmed Inc (RMD)
Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,654,812
  • Shares Outstanding, K 146,931
  • Annual Sales, $ 3,578 M
  • Annual Income, $ 779,440 K
  • 60-Month Beta 0.48
  • Price/Sales 8.91
  • Price/Cash Flow 30.38
  • Price/Book 8.11
Trade RMD with:

Options Overview Details

View History
  • Implied Volatility 22.22% ( -1.21%)
  • Historical Volatility 26.33%
  • IV Percentile 5%
  • IV Rank 6.64%
  • IV High 43.26% on 10/17/22
  • IV Low 20.73% on 05/19/23
  • Put/Call Vol Ratio 1.73
  • Today's Volume 90
  • Volume Avg (30-Day) 123
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 2,245
  • Open Int (30-Day) 2,921

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 1.65
  • Number of Estimates 6
  • High Estimate 1.68
  • Low Estimate 1.62
  • Prior Year 1.49
  • Growth Rate Est. (year over year) +10.74%

Price Performance

See More
Period Period Low Period High Performance
1-Month
214.79 +0.30%
on 05/26/23
243.52 -11.53%
on 04/28/23
-8.48 (-3.79%)
since 04/26/23
3-Month
204.22 +5.49%
on 03/13/23
243.52 -11.53%
on 04/28/23
+3.91 (+1.85%)
since 02/24/23
52-Week
194.30 +10.88%
on 06/16/22
247.65 -13.01%
on 08/11/22
+13.38 (+6.62%)
since 05/26/22

Most Recent Stories

More News
Strong Earnings Results Boost Stocks

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.83%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.80%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.65%....

$SPX : 4,205.45 (+1.30%)
SPY : 420.02 (+1.30%)
$DOWI : 33,093.34 (+1.00%)
DIA : 330.84 (+0.94%)
$IUXX : 14,298.41 (+2.58%)
QQQ : 348.40 (+2.56%)
CHTR : 330.25 (+3.31%)
MHK : 95.10 (+0.52%)
RMD : 215.44 (-0.71%)
RCL : 79.00 (+1.41%)
INTC : 29.00 (+5.84%)
EMN : 81.31 (+0.83%)
Stocks Push Higher on Strength in Corporate Earnings

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.53%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.40%. U.S. stock...

$SPX : 4,205.45 (+1.30%)
SPY : 420.02 (+1.30%)
$DOWI : 33,093.34 (+1.00%)
DIA : 330.84 (+0.94%)
$IUXX : 14,298.41 (+2.58%)
QQQ : 348.40 (+2.56%)
CHTR : 330.25 (+3.31%)
INTC : 29.00 (+5.84%)
MDLZ : 75.13 (-0.07%)
RMD : 215.44 (-0.71%)
EMN : 81.31 (+0.83%)
MHK : 95.10 (+0.52%)
ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates

ResMed (RMD) reports a solid third-quarter top line, led by strong device sales growth through steady production and delivery of its cloud-connected flow generator devices to meet high market demand.

RMD : 215.44 (-0.71%)
JNJ : 154.35 (-0.04%)
ISRG : 306.90 (+1.03%)
EW : 82.01 (+0.44%)
3 Incredible Growth Stocks to Buy Right Now

These mid-cap growth stocks could deliver market-beating returns in 2023 and beyond.

RMD.AX : 33.060 (-0.75%)
BRO : 62.87 (-0.35%)
MKL : 1,328.65 (+1.12%)
RMD : 215.44 (-0.71%)
Reasons Why You Should Retain ResMed (RMD) Stock For Now

Investors are optimistic about ResMed's (RMD) Increased demand for its digital health solution.

RMD : 215.44 (-0.71%)
HAE : 83.21 (+0.40%)
KERN : 0.7500 (-1.32%)
TRSSF : 1.5500 (-6.12%)
EYE vs. RMD: Which Stock Should Value Investors Buy Now?

EYE vs. RMD: Which Stock Is the Better Value Option?

EYE : 25.76 (+1.30%)
RMD : 215.44 (-0.71%)
Reasons Why You Should Retain ResMed (RMD) Stock For Now

Investors are optimistic about ResMed (RMD) owing to the increased demand for its sleep and respiratory care devices.

CAH : 82.83 (-2.21%)
RMD : 215.44 (-0.71%)
MMSI : 81.44 (+0.61%)
AMN : 96.23 (+0.18%)
Top Research Reports for Chevron, Novo Nordisk & Amgen

Today's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), Novo Nordisk A/S (NVO) and Amgen Inc. (AMGN).

GD : 205.25 (+0.44%)
CVX : 154.08 (-0.31%)
NVO : 162.97 (+0.33%)
AMGN : 216.93 (-0.24%)
SBUX : 98.53 (+0.09%)
RMD : 215.44 (-0.71%)
ResMed's (RMD) Mask Sales Drive Growth, Margin Issue Lingers

ResMed (RMD) continues to see robust demand for its market-leading mask portfolio despite being faced with challenges related to lower new patient setups from a competitor recall.

CAH : 82.83 (-2.21%)
RMD : 215.44 (-0.71%)
MMSI : 81.44 (+0.61%)
AMN : 96.23 (+0.18%)
ESLOY vs. RMD: Which Stock Is the Better Value Option?

ESLOY vs. RMD: Which Stock Is the Better Value Option?

ESLOY : 94.8560 (+1.20%)
RMD : 215.44 (-0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory...

See More

Key Turning Points

3rd Resistance Point 221.31
2nd Resistance Point 219.87
1st Resistance Point 217.66
Last Price 215.44
1st Support Level 214.01
2nd Support Level 212.57
3rd Support Level 210.36

See More

52-Week High 247.65
Fibonacci 61.8% 227.27
Fibonacci 50% 220.98
Last Price 215.44
Fibonacci 38.2% 214.68
52-Week Low 194.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar